• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Abbott Laboratories Likely to Reap Benefits from Strategic Split Product Image

Abbott Laboratories Likely to Reap Benefits from Strategic Split

  • Published: November 2011
  • 5 pages
  • GlobalData

Abbott Laboratories Likely to Reap Benefits from Strategic Split - Deal Analysis from GlobalData

Summary

GlobalData, the industry analysis specialist, has released its new report, “Abbott Laboratories Likely to Reap Benefits from Strategic Split”. The report is an essential source of information and analysis on the division of Abbott Laboratories into diversified medical products and research-based pharmaceutical companies. The report provides insights on the rationale of the deal and its strategic implications. Most importantly, the report provides valuable insights on the strategies of pharma companies to deal with the effect of patent cliff. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the pharmaceutical market ahead of the patent cliff. Its scope includes -
- Profiles of the divided companies of Abbott Laboratories
- Rationale behind division of Abbott Laboratories
- Strategic Implications of the spin-off
- Pharma companies juggling READ MORE >

1
1

1.1 List of Tables
2 Summary
3 Abbott Laboratories Likely to Reap Benefits from Strategic Split
3.1 Overview – Creating Two Health Care Companies
3.2 The Division: Company Profiles
3.3 Deal Rationale
3.4 Strategic Implications: The Spin-off
3.5 Pharma Companies Juggle between Strategies Ahead of Patent Cliff
3.6 Companies Overview
3.6.1 Abbott Laboratories (Abbott)
4 Appendix
4.1 Methodology
4.1.1 Coverage
4.1.2 Secondary Research
4.1.3 Primary Research
4.1.4 Expert Panel Validation
4.2 Contact Us
4.3 Disclaimer

1.1 List of Tables
Table 1: Abbott Laboratories – Pipeline Update

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos